Logo Amazing ErasmusMC
NL
  • Homepage
  • Erasmus MC
  • Cookies
  • Disclaimer
  • Privacy

Posts per subject

IV

Pembrolizumab

Immune therapy prevents bladder removal for some bladder cancer patients

A proportion of patients with difficult-to-treat non-metastatic bladder cancer benefit from immunotherapy with the drug pembrolizumab. This has been shown by international research, which Erasmus MC Cancer Institute co-led. Annually, researchers estimate this new therapy could save about 50 patients in the Netherlands from having their bladder removed.

beeld-efficienter-gebruikk-kankermedicatie-1140×642

Oncology

More efficient cancer therapies possible: better for patient, healthcare costs, and environment

Internist and oncologist Stefan Sleijfer and hospital pharmacist Roelof van Leeuwen of Erasmus MC Cancer Institute are working closely together to make cancer therapies more effective. This is not only good for patients, but also for public coffers and for the environment. These efforts save the department of Internal Oncology about EUR 7 million per […]

Erasmus MC
  • Amazing Erasmus MC
  • Erasmus MC
  • Follow us
  • Facebook
  • Instagram
  • Twitter
  • LinkedIn
  • © 2025 Erasmus MC
  • Cookies
  • Disclaimer
  • Privacy